Evidence map›Paper›PMID 11493711›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2001

Type I topoisomerase activity is required for proper chromosomal segregation in Escherichia coli.

Q Zhu, P Pongpech, R J DiGate

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Article
  3. Whole-genome analysis of fiveMicrobiology spectrum · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Synthesis and dissolution of hemicatenanes by type IA DNA topoisomerases.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 4 countries.

Q ZhuMolecular and Cell Biology Program, University of Maryland, Baltimore 21201, USA.
P Pongpech
R J DiGate
University of Maryland, Baltimore · USChulalongkorn University · TH

Funding

Mutational Analysis of E coli DNA Topoisomerase IIIR01GM048445 · NIGMS · UNIVERSITY OF THE SCIENCES PHILADELPHIA · PI DIGATE, RUSSELL J · 1998 to 2005
$1.5M
MUTATIONAL ANALYSIS OF E COLI DNA TOPOISOMERASE IIIR29GM048445 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI DIGATE, RUSSELL J · 1993 to 1997
–
NIGMS NIH HHS GM48445NIGMS NIH HHS R01 GM048445
6 · The paper itself

Abstract

Type I DNA topoisomerases are ubiquitous enzymes involved in many aspects of DNA metabolism. Escherichia coli possesses two type I topoisomerase activities, DNA topoisomerase I (Topo I) and III (Topo III). The gene encoding Topo III (topB) can be deleted without affecting cell viability. Cells possessing a deletion of the gene encoding Topo I (topA) are only viable in the presence of an additional compensatory mutation. In the presence of compensatory mutations, Topo I deletion strains grow normally; however, if Topo III activity is repressed in these cells, they filament extensively and possess an abnormal nucleoid structure. These defects can be suppressed by the deletion of the recA gene, suggesting that these enzymes may be involved in RecA-mediated recombination and may specifically resolve recombination intermediates before partitioning.

Indexed as

AnaphaseEscherichia coli ProteinsBacterial ProteinsChromosomes, BacterialDNA Topoisomerases, Type IEscherichia coliGene DeletionLexA Repressor ProteinMicroscopy, FluorescencePhenotypeRec A RecombinasesRecombinant Fusion ProteinsRecombination, GeneticSerine EndopeptidasesSuppression, GeneticBacterial ProteinsDNA Topoisomerases, Type IEscherichia coli ProteinsLexA Repressor ProteinRec A RecombinasesRecombinant Fusion ProteinsSerine EndopeptidasessulA protein, E coli

Identifiers

PMID11493711
PMCPMC55527
OpenAlexW2157508254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.